Download presentation
Presentation is loading. Please wait.
1
Consultant Paediatric Gastroenterologist
Persistent Diarrhea Dr. Shrish Bhatnagar Consultant Paediatric Gastroenterologist Eras’ Lucknow Medical College & Vivekananda Polyclinic and Institute of Medical Sciences, Lucknow.
3
WHO Definition Diarrhea Duration >/= 14 days acute in onset
following infective etiology Definition excludes specific conditions like celiac disease, tropical sprue, or other congenital, biochemical or metabolic disorders Bulletin of the World Health Organization, 1988, 66:709–717.
4
80% associated with malnutrition
Burden of disease 80% associated with malnutrition WHO CDD Programme; Indian J Med Res 1996;
5
Causes of Persistent diarrhea
Secondary Lactose intolerance Fungal Super-infection Diarrhea compounded by Primary malnutrition……Enteropathy UTI SEPSIS SIBO Antibiotic- associated diarrhea
6
Natural history of diarrhea
Acute diarrhea: 70% resolve in 1 wk Acute diarrhea : 90-95% resolve in 2 wk 5-10% become persistent Majority subsides in 4-6 weeks If persistent beyond >6-8 weeks (small proportion) Think of other causes Ind J Gastroenterol 1993;12:
7
Further prolongation of diarrhea (>6-8 weeks)
Think of Cow’s milk ± soya allergy Immunodeficiency Celiac disease Lymphangiectasia Cystic fibrosis Anatomical causes Refer to a specialist at the earliest
8
Risk factors of disease
Age <1 year Malnutrition Impaired immunity Multiple antibiotics Early introduction of animal milk Occurrence of recent diarrheal episode Reduced intake of breast milk
9
Risk factors of death 6 months of age or less Severe dehydration
Use of total parenteral nutrition Systemic infection: most important WHO Bulletin 1996
10
Stool Pathogens Shigella Salmonella
Isolation in stool : 55-70% Interpretation difficult: excreted in healthy Shigella Salmonella E.coli (Enteropathogenic and enteroaggregative) Giardia lamblia Cryptosporidium Entameba histiolytica Ind J Gastroenterol 1993;12:
11
Management
12
Consequences of diarrhea
Principles Consequences of diarrhea Malnutrition Infections
13
Effects: Secondary lactose intolerance
Prolonged Diarrhea Malnutrition Food allergies (soy, bovine) Compromised immunity Persisting infections Small bowel mucosal injury Superadded infections (fungal) Villous atrophy Loss of brush border enzymes Antibiotics Effects: Secondary lactose intolerance Malabsorption Hypoalbuminemia Bacterial overgrowth
14
Vicious cycle Break!
15
Step 1: Resuscitation Fluid resuscitation: Correction of electrolytes
ORS or Ringer lactate (I.V.) Correction of electrolytes Correction of hypoglycemia
16
Step 2: Identify infections
Look for infections quickly: Respiratory, UTI, Sepsis Examine perineum and oral cavity TLC and DLC Blood and urine culture Chest X-Ray Start appropriate antimicrobials
17
Stool examination No role of routine stool culture and isolation
of pathogen Stool for fungus: budding yeasts and hyphae Stool for C. difficile toxin in a clinical setting: Antibiotic associated diarrhea Stool for opportunistic infections if immunodeficiency is suspected: 3 consecutive fresh samples
18
Indications for antibiotics
Blood in stools: Shigella Systemic infections Severe malnutrition Concomitant UTI <4mo age group No Role of empirical Nitazoxanide for Cryptosporidium Insufficient data to recommend the use of any kind of antibiotic in persistent diarrhoea of unknown cause or non-specific cause BMC Infectious Diseases 2009,
19
Case I: 4 mo girl VPIMS Ofloxacin , racecadotril, probiotics Top fed
Bottle feeding Intt. fever (1000F) 10 days Acute onset, watery 15 times/day for 7 days dehydration Persistent diarrhea 2 weeks 5-6 times/day, small quantities Catheterized
20
Further course… Suspect UTI
Urine exmn: 15 WBC/ hpf Urine culture: E.coli USG-KUB: normal H/O fever Catheterization Suspect UTI Sensitive antibiotics (3rd gen cephalosporin) for 7 days Afebrile Formed stools MCU/ DMSA scan at follow-up (8 weeks): normal
21
Case II: 9mo boy ELMCH Top fed Bottle feeding
No fever or urinary symptoms Acute onset, watery 15 times/day for 7 days Persistent diarrhea 2 weeks 5-6 times/day, small quantities Cefixime 3 days Ofloxacin 5 d Norfloxacin-metranidazole 7 d
22
Satellite lesions around flexures, scrotum and penis
Examination Oral thrush + Soft abdomen No hepatosplenomegaly Other systems normal Perianal erythema + Satellite lesions around flexures, scrotum and penis Curdy white lesions
23
Fungal diarrhea (super-infection)
Diagnosis Fungal diarrhea (super-infection) Stool Budding yeast cells and hyphae ++ Opportunistic infections: no organism C. difficile antigen: negative
24
Management Oral fluconazole 6mg/kg for 10 days Oral Clotrimazole paint
Supplements Diarrhea resolved in 3 days No recurrence
25
Step 3: Lactose intolerance
Load in diet Glucose + Galactose Absorbed Lactase Unabsorbed lactose Acidic Osmotic stool Colon Hydrogen + Lactic acid
26
Persistent diarrhea 3 weeks
Case III: 11 mo boy SPARSH Explosive stools On cow’s milk Acute onset, watery diarrhea for 5 days Persistent diarrhea 3 weeks 10-14 times/day, explosive Ofloxacin 7 days
27
Perianal erythema (widespread) Minimal lesion on scrotum
Examination Soft abdomen No hepatosplenomegaly Other systems normal Perianal erythema (widespread) Minimal lesion on scrotum
28
Cornerstone of management
Step 4: Dietary therapy Cornerstone of management
29
Diet algorithm ? Diet A: Low lactose diet failure
Diet B: Lactose-free diet Diet C: Monosaccharide based diet ? failure May use Green banana diet Hydrolysed or amino acid formulae (Elemental diet) Needs to be revisited in current era failure Total parenteral nutrition
30
Green banana formulation
Basis of use Amylase resistant starch (ARS) Not digested in human intestine Delivered to colon Increase salt, water absorption Provide energy Trophic effect Colonic Bacteria Short chain fatty acids Gastroenterology 2001;121:554-60
31
Step 5: Nutritional supplements
Multivitamins: Twice RDA for 2-4 weeks Iron: after cessation of the diarrhea Folic acid: 1 mg/day for 2 weeks Vitamin A: as per protocol Potassium: 2-3 mEq/kg/day for 2 weeks Magnesium sulphate: 0.2 mL/kg/d IM for 2-3d Zinc: Can be given. No major role
32
Step 6: Monitoring the response
Successful treatment: Diarrhoea: passive (<2 stools/day x 2 consec. days) Adequate food intake Documented weight gain Target: Weight on day 7 > weight at admission Weight gain should be documented on at least 3 successive days Regular follow up
33
How long should we give Diet A or B?
Minimum 7 days trial each before failure is declared If lactose intolerance: Lactose-free diet for at least 21 days
34
Additional drugs Antimotility drugs: Never
Antisecretory (racecadotril): No role in persisted diarrhea Probiotics (Lactobacilli, S. boulardii): weak benefit
35
Case IV: 16 mo boy Sparsh Top fed Bottle feeding
No fever or urinary symptoms Acute onset, watery 15 times/day for 7 days Loose stools , occasional abdominal pain & bloating X 14 days Cefixime 3 days Ofloxacin 5 d Norfloxacin-metranidazole 7 d
36
All Investigation Normal
Further course… Lactulose hydrogen breath test which showed a rise in hydrogen suggestive of “Small intestinal bacterial overgrowth’’. All Investigation Normal Suspect SIBO Substantially under-diagnosed & misdiagnosed entity Frequently implicated as a cause of prolonged diarrhea & abdominal pain. Characterised by an increased number and/or abnormal type of bacteria in the small intestine.
37
SIBO-Pathophysiology 9
SIBO significantly interferes with enzymatic, absorptive and metabolic actions of a macro-organism. Due to injury of the brush-border of enterocytes, the activity of disaccharideses may be decreased. Injured small intestinal mucosa can have undesirable consequences in increased intestinal permeability and/or protein-losing enteropathy. Deficiency of vitamin B12 results from the consumption of this vitamin by anaerobic micro-organisms. Bacteria may also utilise intraluminal protein in the small bowel, this may lead to protein deficiency for the macro-organism and excessive production of ammonia by bacteria. Deconjugation of bile acids by bacteria results in malabsorption of fat and liposoluble vitamins.
38
SIBO Persistent Infectious diarrhoea diarrhea Summing up:-
Infectious diarrhoea can predispose to SIBO and SIBO inturn can lead to prolongation of the diarrhoea. Persistent diarrhea Infectious diarrhoea SIBO Source : Giannattasio, Antonietta, Alfredo Guarino, and Andrea Lo Vecchio. “Management of Children with Prolonged Diarrhea.” F1000Research 5 (2016): F1000 Faculty Rev–206. PMC. Web. 10 May 2016.
39
SIBO-Diagnosis 9 Physical examination provides non specific findings.
Laboratory investigations Complete blood count – anemia may be present Low serum Vit. B12 Low serum prealbumin Microbial investigation of jejunal aspirate obtained by endoscopy (gold standard but has low reproducibility & difficulty in identifying culture resistant organisms) Hydrogen & methane breath analysis by chromatography following oral glucose /lactulose (most commonly used test): Early single peak following oral glucose or double peak after lactulose indicates a positive test.
40
SIBO-Treatment 9 Correction of the underlying cause (dietary/medical/surgical) Nutritional support in patients with weight loss & nutritional deficiency. - Supplementation of vitamin B12 , fat-soluble vitamins, calcium, Folic Acid - Exclusion of lactose from diet. - Reduction of simple sugars - Energy needs conveyed by administering fat & medium chain triacylglyceroles 3) Antibiotics (mainstay of treatment) : A number of antibiotics have been tried for SIBO. Rifaximin appears promising.
41
Rifaximin-Dosing Dosing as per body weight
Dosage for adults and children older than 12 years is 10 to 15 mg/kg/day Younger children a daily dose of 20 to 30 mg/kg/day (Treatment duration 7days) Still not approved for <2 Years of age Prescribing Information- Rifaximin A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Potential in Conditions Mediated by Gastrointestinal Bacteria Jane C. Gillis Rex N. Brogden March 1995, Volume 49, Issue 3, pp First online: 24 October 2012
42
Rifaximin Pharmacokinetics & Safety profile
Unabsorbed from gut ->enables inhibition of enteric pathogens. < 0.4% detected in blood & urine. Undetected in bile, breast milk Excreted unchanged in feces. Half life – 6 hrs No significant drug interactions. Excellent safety profile. Caution advocated in liver disease. Safety in pregnancy not evaluated.
43
Rifaximin efficay & safety in children
Rifaximin being a non absorbable antibiotic with excellent tolerability in adults promises an ideal drug for use in children with Travelers Diarrhea & SIBO. A meta-analysis of studies of Rifaximin in children was conducted by Fabio Capello et al. 11 Search Methods: All available publications related to use of rifaximin in children included Results: Higher number of healed patients in the rifaximin groups at the end of the studies, with a reduction of the mean number of stool/day (-2,021; p<0,001); more formed stool (OR 4,31; p=0,001); a shorter Recovery Time when compared to control groups. The microbiological tests performed after treatment have shown the persistence of 54% of the potentially most dangerous pathogenic bacteria in the children treated with diet and rehydration alone, in comparison with 11.2% in children treated with rifaximin . (chi square 7.4; p= 0.02). Conclusions: Use of rifaximin for bacterial diarrhea in children over 2 years may be fully justified in selected circumstances as in case of travelers' diarrhea, recurrent or relapsing diarrhea known or supposed to be caused by non-invasive Bacterial over growth
44
Summary Infections, malnutrition form vicious cycle
Persistent diarrhea > 14 days Infections, malnutrition form vicious cycle UTI, Fungal Infection ,Secondary lactose intolerance, SIBO are cause for prolongation Home Based Dietary Management with correction of prolongation factor is the main stay of treatment Rifaximin has a role in SIBO in children
45
Preparation of green banana diet
Raw, green banana Remove skin Take pulp, blend Homogenized 100 g Cook in boiling water For 7-10 minutes + Oil 25 g Glucose 20 g Nacl 01 g ± Egg white 80 g Rice 10 g powder Cook in one liter water + Feed Calories: 54/100ml
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.